Joel Greenblatt Sage Therapeutics, Inc. Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$40.26 - $57.37 $1.4 Million - $2 Million
-34,832 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$54.88 - $79.29 $622,119 - $898,831
11,336 Added 48.25%
34,832 $1.98 Million
Q1 2021

May 17, 2021
BUY
$70.65 - $96.76 $1.66 Million - $2.27 Million
23,496 New
23,496 $1.76 Million

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email